Water is the first thing these particles encounter in the body
At the threshold between chemistry and medicine, researchers at Arizona State University have discovered that water — the most elemental substance in biology — holds the key to how nanoparticles behave inside the human body. Published in the Proceedings of the National Academy of Sciences, their work reveals that the thermodynamic relationship between water molecules and nanoparticle surfaces can predict whether a drug delivery system will succeed or fail. In doing so, they have offered medicine something rare: not just a finding, but a framework — a way to design treatments that reach only what needs to be reached, and spare what does not.
- Current chemotherapy floods the entire body with toxic agents, destroying healthy cells alongside cancerous ones — a blunt instrument where precision is desperately needed.
- The core discovery is that water is the first gatekeeper: how a nanoparticle's surface interacts with water molecules upon entering the body determines whether it survives long enough to deliver its cargo.
- Three biological coatings — protein, starch, and fatty acid — each produced dramatically different water interactions, with the fatty acid forming a partial bilayer that may allow particles to evade immune detection and circulate longer.
- The team has built a thermodynamic framework that transforms nanoparticle design from trial-and-error into a predictive science, mapping water behavior to biological performance.
- The trajectory points toward cancer treatments that deliver chemotherapy exclusively to tumor sites, reducing the devastating side effects that make current therapies so difficult to endure.
Scientists at Arizona State University have uncovered something quietly profound: water, the body's most abundant molecule, plays a decisive and previously underestimated role in whether nanoparticle drug delivery systems succeed. Their study, published in the Proceedings of the National Academy of Sciences, shows that by measuring hydration energy — the thermodynamic interaction between water and a nanoparticle's outer surface — researchers can predict how that particle will behave once inside a living organism.
The promise of nanomedicine has always been precision: delivering drugs directly to diseased tissue rather than saturating the entire body. Chemotherapy's brutal side effects stem from exactly this lack of targeting — healthy cells suffer alongside cancerous ones. A nanoparticle that can navigate to a tumor and release its payload there, without triggering the immune system along the way, would change the calculus of cancer treatment entirely.
To explore this, the team coated magnetite nanoparticles with three different biological materials: a protein, a starch, and a fatty acid. Each produced a distinct water interaction profile. Protein coatings showed strong but irregular contact with water, potentially flagging the particle as foreign to the immune system. Starch created a more uniformly water-compatible surface, suggesting better cellular tolerance. The fatty acid proved most striking — it arranged itself into a partial bilayer structure that both increased water interaction and appeared to suppress immune activation, giving the particle more time to circulate and reach its target.
What the researchers have built is not merely an observation but a predictive tool. By linking water interaction to biological behavior, scientists can now engineer nanoparticles with intentional properties — stability, immune evasion, targeted delivery — rather than discovering them by chance. For patients enduring chemotherapy, the framework points toward a future where treatment is precise enough to spare what is healthy, and powerful enough to reach what is not.
Scientists at Arizona State University have identified something fundamental about how drugs move through the body: water matters more than anyone realized. The finding, published in the Proceedings of the National Academy of Sciences, concerns the precise way water molecules interact with the surface of nanoparticles designed to deliver medicine. It sounds abstract, but the implications are concrete. If researchers can predict how water behaves around these tiny particles, they can design drug delivery systems that work better, last longer in the bloodstream, and cause fewer of the devastating side effects that plague current treatments like chemotherapy.
The research centers on what scientists call hydration energy—essentially, the thermodynamic dance between water and the outer surface of nanoparticles coated with biological molecules. Navrotsky, the study's lead author, explains that water is the first thing these particles encounter when they enter the body. By measuring that initial interaction, researchers can forecast how the particles will behave once inside a living organism. This matters because nanomedicine has enormous promise but faces real obstacles. The goal is to deliver drugs directly to diseased tissue—a tumor, for instance—rather than flooding the entire body with toxic substances. Current chemotherapy does exactly that, poisoning healthy cells along with cancerous ones. A more precise delivery system could change that equation.
To test their theory, the team constructed nanoparticles from magnetite and wrapped them in three different biological coatings: a protein, a polysaccharide (starch), and a fatty acid. Using sensitive measurement techniques, they tracked how each coating altered the particle's interaction with water and, by extension, how the body's immune system would respond to it. The results revealed striking differences. Protein-coated particles showed strong initial water interaction but with irregular zones that might trigger immune recognition—the body's defense system flagging the particle as foreign. Starch coating created a more water-loving surface with weaker interactions overall, which could mean better compatibility with cells and less immune interference. The fatty acid case proved most intriguing: when it adhered to the nanoparticle, it formed a partial bilayer structure that increased water interaction while potentially stabilizing the particle and suppressing immune activation. That last property matters enormously—a particle that can circulate longer without being attacked by white blood cells has more time to reach its target.
What the researchers have constructed is a thermodynamic framework that directly links water interaction to biological performance. It is, in essence, a predictive tool. Rather than building nanoparticles through trial and error, scientists can now use this understanding to design particles with specific properties: stability, immune evasion, drug-carrying capacity. The implications extend beyond cancer, though that is where the most immediate application lies. A treatment that delivers chemotherapy only to tumor cells, sparing healthy tissue, would reduce the brutal side effects that make cancer therapy so difficult to endure. The framework suggests that such precision is not a distant dream but an engineering problem with a solution within reach.
Citas Notables
Water is the first element that enters in contact with these particles in the biological environment, so measuring this interaction allows us to anticipate their behavior inside the body— Navrotsky, lead author of the study
La Conversación del Hearth Otra perspectiva de la historia
Why does water interaction matter so much? Isn't the drug itself the important part?
The drug is important, but it's useless if the particle carrying it gets destroyed before reaching the tumor. Water is the environment. The moment a nanoparticle enters the bloodstream, water molecules surround it. If those interactions are wrong, the immune system recognizes it as a threat and eliminates it.
So you're saying the coating is like a disguise?
More like a passport. The coating determines how the particle presents itself to the body. A protein coating might look too foreign. Starch looks more natural. Fatty acid creates a structure that actually blends in better.
And they can predict this now just by measuring water interaction?
That's the breakthrough. Before, you had to build the particle and test it in the body. Now you can measure hydration energy and know in advance whether it will work.
What happens to the particles that don't work?
The immune system attacks them. They get cleared from the bloodstream before they reach the tumor. The drug never gets delivered. The patient gets side effects from the drug circulating everywhere else.
So this could actually reduce suffering?
That's the point. Chemotherapy is brutal because it poisons the whole body. If you can deliver it only to cancer cells, you spare healthy tissue. Fewer side effects. Better outcomes.
How soon could this be in actual treatments?
That's the question. The framework is proven. Now it needs to move from the lab into clinical trials. That takes years. But the path is clear.